Evotec Investor
Evotec is a drug discovery alliance company providing drug discovery solutions to pharmaceutical and biotechnology companies.
Founded Date:
1993-01-01
Technology:
Biopharma, Biotechnology, Pharmaceutical
Investor Type:
Not Classified
Funding Status:
IPO
Total Funding:
733436691.0
Employee Number:
1001-5000
Headquarters:
Hamburg, Hamburg, Germany
Last Funding Date:
2023-02-10
Investors Number:
10.0
Last Funding Type:
Post-IPO Debt
Estimated Revenue:
$100M to $500M
Acquisitions Number:
Made Acquisitions
Number Of Exists:
2
Industry:
End-to-End Drug Development